|
one more thing...I consulted w/Dr. Larry Norton @Memorial Sloan Kettering-he's the head of breast oncology & a large contributor to the development of Herceptin and very, very research oriented.
When I asked about the use of thalidomide, off-label, he instantly said "Absolutely not.Certainly not unless in clinical trial."
It seems to be an uphill battle!
|
Linear Mode
